Published in Thyroid on August 01, 2001
How I treat late effects in adults after allogeneic stem cell transplantation. Blood (2010) 1.26
Management of subclinical hypothyroidism: the thyroidologists' view. Eur Thyroid J (2012) 1.09
Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. J Physiol (2007) 0.93
International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey. Br J Gen Pract (2015) 0.91
Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am (2012) 0.86
Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab (2014) 0.82
Geriatric thyroidology: An update. Indian J Endocrinol Metab (2012) 0.78
The Colorado thyroid disease prevalence study. Arch Intern Med (2000) 7.84
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med (1981) 3.46
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Postinjury multiple organ failure: a bimodal phenomenon. J Trauma (1996) 2.69
Early predictors of postinjury multiple organ failure. Arch Surg (1994) 2.21
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med (1984) 1.88
Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol (1989) 1.86
Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes. J Biol Chem (1989) 1.84
Anatomic relationship between the pubic symphysis and ischial spines and its clinical significance in the assessment of fetal head engagement and station during labor. Ultrasound Obstet Gynecol (2009) 1.80
Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med (1997) 1.75
Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab (2001) 1.72
Multiple organ failure can be predicted as early as 12 hours after injury. J Trauma (1998) 1.66
Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol (1991) 1.65
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Reduced risk of IDDM among breast-fed children. The Colorado IDDM Registry. Diabetes (1988) 1.55
Thyroid hormone resistance syndromes. Am J Med (1993) 1.54
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
Hard-rock mining exposures affect smokers and nonsmokers differently. Results of a community prevalence study. Am Rev Respir Dis (1989) 1.52
Early risk factors for postinjury multiple organ failure. World J Surg (1996) 1.46
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Oncogene (2006) 1.45
Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab (1995) 1.43
Contractor safety practices and injury rates in construction of the Denver International Airport. Am J Ind Med (1999) 1.41
Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid (1994) 1.41
Analysis of construction injury burden by type of work. Am J Ind Med (2000) 1.40
The questionable value of medical screening in the small-group health insurance market. Health Aff (Millwood) (1995) 1.39
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem (1985) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr (1981) 1.30
A new method to assess fetal head descent in labor with transperineal ultrasound. Ultrasound Obstet Gynecol (2009) 1.29
Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med (1983) 1.29
Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest (1973) 1.27
Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol (2006) 1.27
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab (1978) 1.24
The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int (1989) 1.24
Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol (1994) 1.20
Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. J Clin Invest (1985) 1.20
Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation (2001) 1.17
Structured research training in residency training programs. The impact on the level of resident research activity. Am J Phys Med Rehabil (1994) 1.16
The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab (1976) 1.15
Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med (1999) 1.13
Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med (1979) 1.13
Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab (1975) 1.10
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab (1981) 1.08
MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with Pit-1 and GATA-2 on the thyrotropin-beta promoter in thyrotropes. Mol Endocrinol (2006) 1.06
Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab (1977) 1.05
Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab (1976) 1.05
Complications of surgery in hypothyroid patients. Am J Med (1984) 1.03
Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med (1988) 1.01
Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment. J Pediatr (1982) 1.00
Cell-specific expression of the mouse glycoprotein hormone alpha-subunit gene requires multiple interacting DNA elements in transgenic mice and cultured cells. Mol Endocrinol (1998) 1.00
Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils. J Clin Invest (1985) 1.00
The thyrotropin beta-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse T alphaT1 cells. Endocrinology (1998) 1.00
Reversible alteration of the visual evoked potential in hypothyroidism. Am J Med (1984) 1.00
Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1981) 0.99
Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ann Intern Med (1984) 0.99
Molecular biology of thyrotropin. Endocr Rev (1989) 0.97
Therapy of primary hypothyroidism with L-triiodothyronine: discordant cardiac and pituitary responses. Clin Endocrinol (Oxf) (1980) 0.97
Impairment after burns: a two-center, prospective report. Burns (2003) 0.97
Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects. Am J Clin Nutr (1998) 0.95
Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem (1997) 0.95
Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg (1987) 0.94
Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men. Med Care (1998) 0.94
Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet (1990) 0.94
An alpha-subunit-secreting cell line derived from a mouse thyrotrope tumor. Mol Endocrinol (1990) 0.94
Rapid pituitary and peripheral tissue responses to intravenous L-triiodothyronine in hypothyroidism. J Clin Endocrinol Metab (1983) 0.93
Regulation of the alpha and thyrotropin beta-subunit messenger ribonucleic acids by thyroid hormones. Endocrinology (1985) 0.92
Transcriptional regulation of thyrotropin subunit genes by thyrotropin-releasing hormone and dopamine in pituitary cell culture. J Biol Chem (1986) 0.92
Time off work and return to work rates after burns: systematic review of the literature and a large two-center series. J Burn Care Rehabil (2001) 0.92
Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann Intern Med (1972) 0.92
Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med (1979) 0.91
Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest (1987) 0.91
Metabolic clearance and production rates of prolactin in man. J Clin Invest (1979) 0.91
N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone. Mol Endocrinol (1995) 0.91
Pure alpha-secreting pituitary adenomas. N Engl J Med (1981) 0.90
Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. J Clin Invest (2000) 0.90
Methimazole pharmacology in the rat: studies using a newly developed radioimmunoassay for methimazole. Endocrinology (1984) 0.89
Regulation by thyroxine of the mRNA encoding the alpha subunit of mouse thyrotropin. J Biol Chem (1983) 0.89
Analysis of DNA sequences required for pituitary-specific expression of the glycoprotein hormone alpha-subunit gene. Mol Endocrinol (1992) 0.89
Effects of hydrocortisone on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab (1994) 0.89
Metabolic clearance and secretion rates of subunits of human thyrotropin. J Clin Invest (1977) 0.89
Early peripheral responses to intravenous L-thyroxine in primary hypothyroidism. Am J Med (1982) 0.89
Metabolic clearance and production rates of human thyrotropin. J Clin Invest (1974) 0.89
Colorado IDDM Registry. Incidence and validation of IDDM in children aged 0-17 yr. Diabetes Care (1990) 0.87
Diagnostic capabilities of fractal dimension and mandibular cortical width to identify men and women with decreased bone mineral density. Osteoporos Int (2011) 0.86
Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg (1987) 0.86
Comparison of hospitalization between nursing home and community residents. J Am Geriatr Soc (1985) 0.86
Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med (1980) 0.86
Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function. Endocrinology (1983) 0.86
Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med (1982) 0.85
Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay. J Clin Endocrinol Metab (1982) 0.85